Regeneron Pharmaceuticals Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A whale has taken a bearish stance on Regeneron Pharmaceuticals (NASDAQ:REGN), with 75% of detected unusual options trades being bearish. Whales have been targeting a price range of $600 to $880 for REGN over the last 3 months. Analysts have mixed ratings, with price targets ranging from $811 to $1050.
May 30, 2023 | 6:31 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A whale has taken a bearish stance on Regeneron Pharmaceuticals, with 75% of detected unusual options trades being bearish. Analysts have mixed ratings, with price targets ranging from $811 to $1050.
The bearish stance taken by a whale with a significant amount of money to spend indicates a potential short-term negative impact on Regeneron Pharmaceuticals' stock price. Additionally, the mixed analyst ratings and wide range of price targets suggest uncertainty in the market, which could contribute to downward pressure on the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100